Literature DB >> 12117724

Opposing functions of the Ets factors NERF and ELF-1 during chicken blood vessel development.

John Gaspar1, Shelley Thai, Carole Voland, Antoinise Dube, Towia A Libermann, M Luisa Iruela-Arispe, Peter Oettgen.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate the role of the Ets factor NERF in the regulation of the Tie1 and Tie2 genes during chicken blood vessel development. METHODS AND
RESULTS: We have isolated the full-length cDNA for the chicken homologue of the human Ets factor NERF2 (cNERF2). Northern blot analysis and in situ hybridization demonstrate that cNERF2 is enriched in the developing blood vessels of the chicken chorioallantoic membrane. Interestingly, cNERF2 functions as a competitive inhibitor of a highly related Ets factor cELF-1, which we have previously shown to be enriched in chicken blood vessel development. Although in vitro-translated cELF-1 and cNERF2 can bind equally well to conserved Ets binding sites in the promoters of the Tie1 and Tie2 genes, cELF-1 preferentially binds to the Ets sites in these promoters during early stages of chicken blood vessel development, suggesting that cNERF may bind during later stages of blood vessel development and vascular remodeling.
CONCLUSIONS: cNERF2 is enriched during embryonic and extraembryonic blood vessel development in the chicken and facilitates tight control of Tie1 and Tie2 gene regulation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12117724     DOI: 10.1161/01.atv.0000023427.92642.cd

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  7 in total

1.  Critical role for the Ets transcription factor ELF-1 in the development of tumor angiogenesis.

Authors:  Xuling Huang; Courtney Brown; Weihua Ni; Elizabeth Maynard; Alan C Rigby; Peter Oettgen
Journal:  Blood       Date:  2005-12-13       Impact factor: 22.113

2.  The transcription factor E74-like factor controls quiescence of endothelial cells and their resistance to myeloablative treatments in bone marrow.

Authors:  Mariela Sivina; Takeshi Yamada; Chun Shik Park; Monica Puppi; Suleyman Coskun; Karen Hirschi; H Daniel Lacorazza
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-02-24       Impact factor: 8.311

3.  Antiinflammatory effects of the ETS factor ERG in endothelial cells are mediated through transcriptional repression of the interleukin-8 gene.

Authors:  Lei Yuan; Vesna Nikolova-Krstevski; Yumei Zhan; Maiko Kondo; Manoj Bhasin; Laya Varghese; Kiichiro Yano; Chris V Carman; William C Aird; Peter Oettgen
Journal:  Circ Res       Date:  2009-04-09       Impact factor: 17.367

Review 4.  ETS transcription factors in embryonic vascular development.

Authors:  Michael P Craig; Saulius Sumanas
Journal:  Angiogenesis       Date:  2016-04-28       Impact factor: 9.596

5.  The antiproliferative ELF2 isoform, ELF2B, induces apoptosis in vitro and perturbs early lymphocytic development in vivo.

Authors:  Fiona H X Guan; Charles G Bailey; Cynthia Metierre; Patrick O'Young; Dadi Gao; Teh Liane Khoo; Jeff Holst; John E J Rasko
Journal:  J Hematol Oncol       Date:  2017-03-28       Impact factor: 17.388

Review 6.  Roles and regulations of the ETS transcription factor ELF4/MEF.

Authors:  Mary Ann Suico; Tsuyoshi Shuto; Hirofumi Kai
Journal:  J Mol Cell Biol       Date:  2017-06-01       Impact factor: 6.216

7.  Uterine gene expression in the live-bearing lizard, Chalcides ocellatus, reveals convergence of squamate reptile and mammalian pregnancy mechanisms.

Authors:  Matthew C Brandley; Rebecca L Young; Dan L Warren; Michael B Thompson; Günter P Wagner
Journal:  Genome Biol Evol       Date:  2012-02-14       Impact factor: 3.416

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.